Global Transcatheter Aortic Valve Replacement (TAVR) Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch＇s in-depth investigation and research, the global Transcatheter Aortic Valve Replacement (TAVR) market size will reach 10,573 Million USD in 2025 and is projected to reach 21,484 Million USD by 2032, with a CAGR of 10.66% (2025-2032). Notably, the China Transcatheter Aortic Valve Replacement (TAVR) market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Transcatheter Aortic Valve Replacement (TAVR) is a minimally invasive medical procedure used to treat aortic valve stenosis, a condition where the aortic valve narrows and restricts blood flow from the heart to the rest of the body. Unlike traditional open-heart surgery, TAVR is performed by threading a catheter through blood vessels, often starting in the leg, to reach the heart. Once in position, a replacement valve is deployed, pushing aside the diseased valve and restoring normal blood flow. TAVR is particularly beneficial for patients who may be at higher risk for complications with traditional surgery. The procedure has revolutionized the treatment of aortic valve stenosis, offering reduced recovery times, shorter hospital stays, and providing a viable option for those who were previously considered ineligible for surgery. However, the suitability of TAVR for an individual patient is determined based on various factors, and the decision is made in consultation with a heart care team.
The major global suppliers of Transcatheter Aortic Valve Replacement (TAVR) include Edwards Lifesciences, Medtronic, Abbott, Boston Scientific, Meril Life Sciences, Venus Medtech, Bracco (HLT), JenaValve Technology, Suzhou Jiecheng Medical Technology Co., Peijia Medical, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Transcatheter Aortic Valve Replacement (TAVR). Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Transcatheter Aortic Valve Replacement (TAVR) market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Transcatheter Aortic Valve Replacement (TAVR) market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Transcatheter Aortic Valve Replacement (TAVR) industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Transcatheter Aortic Valve Replacement (TAVR) Include:
Edwards Lifesciences
Medtronic
Abbott
Boston Scientific
Meril Life Sciences
Venus Medtech
Bracco (HLT)
JenaValve Technology
Suzhou Jiecheng Medical Technology Co.
Peijia Medical
Transcatheter Aortic Valve Replacement (TAVR) Product Segment Include:
Transfemoral Approach
Transapical Approach
Others
Transcatheter Aortic Valve Replacement (TAVR) Product Application Include:
Aortic Stenosis
Aortic Regurgitation
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Transcatheter Aortic Valve Replacement (TAVR) Industry PESTEL Analysis
Chapter 3: Global Transcatheter Aortic Valve Replacement (TAVR) Industry Porter's Five Forces Analysis
Chapter 4: Global Transcatheter Aortic Valve Replacement (TAVR) Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Transcatheter Aortic Valve Replacement (TAVR) Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Transcatheter Aortic Valve Replacement (TAVR) Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Transcatheter Aortic Valve Replacement (TAVR) Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch＇s in-depth investigation and research, the global Transcatheter Aortic Valve Replacement (TAVR) market size will reach 10,573 Million USD in 2025 and is projected to reach 21,484 Million USD by 2032, with a CAGR of 10.66% (2025-2032). Notably, the China Transcatheter Aortic Valve Replacement (TAVR) market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Transcatheter Aortic Valve Replacement (TAVR) is a minimally invasive medical procedure used to treat aortic valve stenosis, a condition where the aortic valve narrows and restricts blood flow from the heart to the rest of the body. Unlike traditional open-heart surgery, TAVR is performed by threading a catheter through blood vessels, often starting in the leg, to reach the heart. Once in position, a replacement valve is deployed, pushing aside the diseased valve and restoring normal blood flow. TAVR is particularly beneficial for patients who may be at higher risk for complications with traditional surgery. The procedure has revolutionized the treatment of aortic valve stenosis, offering reduced recovery times, shorter hospital stays, and providing a viable option for those who were previously considered ineligible for surgery. However, the suitability of TAVR for an individual patient is determined based on various factors, and the decision is made in consultation with a heart care team.
The major global suppliers of Transcatheter Aortic Valve Replacement (TAVR) include Edwards Lifesciences, Medtronic, Abbott, Boston Scientific, Meril Life Sciences, Venus Medtech, Bracco (HLT), JenaValve Technology, Suzhou Jiecheng Medical Technology Co., Peijia Medical, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Transcatheter Aortic Valve Replacement (TAVR). Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Transcatheter Aortic Valve Replacement (TAVR) market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Transcatheter Aortic Valve Replacement (TAVR) market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Transcatheter Aortic Valve Replacement (TAVR) industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Transcatheter Aortic Valve Replacement (TAVR) Include:
Edwards Lifesciences
Medtronic
Abbott
Boston Scientific
Meril Life Sciences
Venus Medtech
Bracco (HLT)
JenaValve Technology
Suzhou Jiecheng Medical Technology Co.
Peijia Medical
Transcatheter Aortic Valve Replacement (TAVR) Product Segment Include:
Transfemoral Approach
Transapical Approach
Others
Transcatheter Aortic Valve Replacement (TAVR) Product Application Include:
Aortic Stenosis
Aortic Regurgitation
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Transcatheter Aortic Valve Replacement (TAVR) Industry PESTEL Analysis
Chapter 3: Global Transcatheter Aortic Valve Replacement (TAVR) Industry Porter's Five Forces Analysis
Chapter 4: Global Transcatheter Aortic Valve Replacement (TAVR) Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Transcatheter Aortic Valve Replacement (TAVR) Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Transcatheter Aortic Valve Replacement (TAVR) Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Transcatheter Aortic Valve Replacement (TAVR) Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Transcatheter Aortic Valve Replacement (TAVR) Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Transcatheter Aortic Valve Replacement (TAVR) Product by Type
- 1.2.1 Transfemoral Approach
- 1.2.2 Transapical Approach
- 1.2.3 Others
- 1.3 Transcatheter Aortic Valve Replacement (TAVR) Product by Application
- 1.3.1 Aortic Stenosis
- 1.3.2 Aortic Regurgitation
- 1.3.3 Others
- 1.4 Global Transcatheter Aortic Valve Replacement (TAVR) Market Size Analysis (2020-2032)
- 1.5 Transcatheter Aortic Valve Replacement (TAVR) Market Development Status and Trends
- 1.5.1 Transcatheter Aortic Valve Replacement (TAVR) Industry Development Status Analysis
- 1.5.2 Transcatheter Aortic Valve Replacement (TAVR) Industry Development Trends Analysis
- 2 Transcatheter Aortic Valve Replacement (TAVR) Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Transcatheter Aortic Valve Replacement (TAVR) Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Transcatheter Aortic Valve Replacement (TAVR) Market Analysis by Country
- 4.1 Global Transcatheter Aortic Valve Replacement (TAVR) Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Transcatheter Aortic Valve Replacement (TAVR) Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Transcatheter Aortic Valve Replacement (TAVR) Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Transcatheter Aortic Valve Replacement (TAVR) Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Transcatheter Aortic Valve Replacement (TAVR) Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Transcatheter Aortic Valve Replacement (TAVR) Market Revenue and Growth Rate (2020-2032)
- 4.5 China Transcatheter Aortic Valve Replacement (TAVR) Market Revenue and Growth Rate (2020-2032)
- 4.6 France Transcatheter Aortic Valve Replacement (TAVR) Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Transcatheter Aortic Valve Replacement (TAVR) Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Transcatheter Aortic Valve Replacement (TAVR) Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Transcatheter Aortic Valve Replacement (TAVR) Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Transcatheter Aortic Valve Replacement (TAVR) Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Transcatheter Aortic Valve Replacement (TAVR) Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Transcatheter Aortic Valve Replacement (TAVR) Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Transcatheter Aortic Valve Replacement (TAVR) Market Revenue and Growth Rate (2020-2032)
- 4.14 India Transcatheter Aortic Valve Replacement (TAVR) Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Transcatheter Aortic Valve Replacement (TAVR) Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Transcatheter Aortic Valve Replacement (TAVR) Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Transcatheter Aortic Valve Replacement (TAVR) Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Transcatheter Aortic Valve Replacement (TAVR) Market Revenue by Key Suppliers (2021-2025)
- 5.2 Global Transcatheter Aortic Valve Replacement (TAVR) Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Transcatheter Aortic Valve Replacement (TAVR) Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Transcatheter Aortic Valve Replacement (TAVR) Market Analysis by Type
- 6.1 Global Transcatheter Aortic Valve Replacement (TAVR) Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Transcatheter Aortic Valve Replacement (TAVR) Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Edwards Lifesciences
- 7.1.1 Edwards Lifesciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Edwards Lifesciences Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio
- 7.1.3 Edwards Lifesciences Transcatheter Aortic Valve Replacement (TAVR) Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Medtronic
- 7.2.1 Medtronic Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Medtronic Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio
- 7.2.3 Medtronic Transcatheter Aortic Valve Replacement (TAVR) Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 Abbott
- 7.3.1 Abbott Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Abbott Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio
- 7.3.3 Abbott Transcatheter Aortic Valve Replacement (TAVR) Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 Boston Scientific
- 7.4.1 Boston Scientific Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Boston Scientific Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio
- 7.4.3 Boston Scientific Transcatheter Aortic Valve Replacement (TAVR) Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 Meril Life Sciences
- 7.5.1 Meril Life Sciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Meril Life Sciences Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio
- 7.5.3 Meril Life Sciences Transcatheter Aortic Valve Replacement (TAVR) Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 Venus Medtech
- 7.6.1 Venus Medtech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Venus Medtech Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio
- 7.6.3 Venus Medtech Transcatheter Aortic Valve Replacement (TAVR) Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 Bracco (HLT)
- 7.7.1 Bracco (HLT) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Bracco (HLT) Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio
- 7.7.3 Bracco (HLT) Transcatheter Aortic Valve Replacement (TAVR) Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 JenaValve Technology
- 7.8.1 JenaValve Technology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 JenaValve Technology Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio
- 7.8.3 JenaValve Technology Transcatheter Aortic Valve Replacement (TAVR) Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 Suzhou Jiecheng Medical Technology Co.
- 7.9.1 Suzhou Jiecheng Medical Technology Co. Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Suzhou Jiecheng Medical Technology Co. Transcatheter Aortic Valve Replacement (TAVR) Product Portfolio
- 7.9.3 Suzhou Jiecheng Medical Technology Co. Transcatheter Aortic Valve Replacement (TAVR) Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.10 Peijia Medical
- 7.10.1 Peijia Medical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Peijia Med
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
